Operating
Accounts Payable
Roivant Sciences Accounts Payable increased by 505.1% to $16.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9890.9%, from -$165.00K to $16.16M.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ4 2025May 20, 2026
How to read this metric
An increase indicates the company is delaying payments to preserve cash, while a decrease indicates the company is paying down its obligations.
Detailed definition
Measures the change in amounts owed to suppliers and vendors for goods and services received. It serves as a source of i...
Peer comparison
A standard working capital metric used to assess short-term liquidity management and supplier payment terms.
Metric ID:
operating_increase_decrease_in_accounts_payable_tradeHistorical Data
14 periods
| Q1 '21 | Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$6.34M | $62.85M | $11.71M | -$19.45M | $26.23M | $7.20M | $11.94M | $20.89M | -$25.27M | -$165.00K | -$11.75M | $3.00M | -$3.99M | $16.16M |
| QoQ Change | — | >999% | -81.4% | -266.1% | +234.8% | -72.6% | +65.9% | +74.9% | -221.0% | +99.3% | <-999% | +125.5% | -233.1% | +505.1% |
| YoY Change | — | — | — | -206.7% | -58.3% | — | +161.4% | — | -311.6% | -100.8% | +53.5% | — | — | >999% |
Range-$25.27M – $62.85M
CAGR+33.3%
Avg YoY Growth>999%
Median YoY Growth-58.3%
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's accounts payable?
- Roivant Sciences (ROIV) reported accounts payable of $16.16M in Q1 2026.
- How has Roivant Sciences's accounts payable changed year-over-year?
- Roivant Sciences's accounts payable increased by 9890.9% year-over-year, from -$165.00K to $16.16M.
- What does accounts payable mean?
- The change in the amount of money the company owes to its suppliers.